Extranodal type T/NK-cell lymphoma with an atypical clinical presentation

Pediatric Hematology and Oncology

Volumn 24, Issue 4, 2007, Pages 291-299

  Aydin, G Burça ^a,b   Akyuz, Canan ^a   Talim, Beril ^a   Evans, Sibel Ersoy ^a   Sahin, Sedef ^a   Sari, Neriman ^a   Tabanlioglu, Duru ^a   Özen, Seza ^a   Çaǧlar, Melda ^a   Büyükpamukçu, Münevver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Angora Evleri   (Turkey)

Author keywords

CAEBV; T NK cell lymphoma; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; STEROID; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; CEREBROSPINAL FLUID EXAMINATION; CHILDHOOD CANCER; CLINICAL FEATURE; DISEASE COURSE; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FEBRILE NEUTROPENIA; FEMALE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HOSPITAL ADMISSION; HUMAN; HYPERSENSITIVITY; INSECT BITE; KIDNEY; LYMPH NODE BIOPSY; MENINX; NATURAL KILLER CELL; PANCREAS; PERIPHERAL T CELL LYMPHOMA; SKIN; SPLEEN; TREATMENT OUTCOME;

ADOLESCENT; CLONE CELLS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; TISSUE DISTRIBUTION;

EID: 34347371225     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010701441112     Document Type: Article

References (20)

1. Dearden CE, Foss FM. Peripheral T-cell lymphomas: diagnosis and management. Hematol Oncol Clin North Am. 2003;17:1351-1366.
2. + hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol. 2004;15:1097-1108.
3. Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol. 2004;28:719-735.
4. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas: report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610-627.
5. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
6. Kanegane H, Nomura K, Miyawaki T, et al. Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies. Crit Rev Oncol Hematol. 2002;44:239-249.
7. Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003;187:527-533.
8. Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005;80:64-69.
9. Yachie A, Kanegane H, Kasahara Y. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases. Semin Hematol. 2003;40:124-132.
10. Smoller BR, Santucci M, Wood GS, et al. Histopathology and genetics of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am. 2003;17:1277-1311.
11. Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer. 2004;101:1404-1413.
12. Kim GE, Koom WS, Yang WI, et al. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Head Neck. 2004;26:584-593.
13. Li CC, Tien HF, Tang JL, et al. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer. 2004;100:366-375.
14. Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood. 1997;89:4501-4513.
15. Suzumiya J, Takeshita M, Kimura N. Sinonasal malignant lymphoma of natural killer cell phenotype associated with diffuse pancreatic involvement. Leuk Lymphoma. 1993;10:231-236.
16. Hamzaoui M, Essid A, Sahli S, et al. Nasal angiocentric T cell-natural killer cell lymphoma with pancreatic localisation in a child. Arch Pediatr. 2003;10:979-982.
17. Kuwabara H, Tsuji M, Yoshii Y, et al. Nasal-type NK/T cell lymphoma of the orbit with distant metastases. Hum Pathol. 2003;34:290-292.
18. Wex H, Aumann V, Hausler M, et al. Chronic natural killer cell lymphocytosis is associated with elevated cytotoxic activity of natural killer cells. J Pediatr Hematol Oncol. 2005;27:85-89.
19. Kimura H, Hoshino Y, Hara S, et al. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis. 2005;191:531-539.
20. Suzuki K, Ohshima K, Karube K, et al. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Int J Oncol. 2004;24:1165-1174.